Concepedia

Author

Yoko Amada

Astellas Pharma (Japan)

Also Known As

Yoko Amada

6

Publications

98

Citations

4

H-Index

11

Concepts

All Affiliations

Astellas Pharma (Japan)
YA

About

Yoko Amada is an author at Astellas Pharma (Japan) specializing in neuropharmacology, neurophysiology, and synaptic transmission.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

10

2

Medicine

1

1

10

3

Neuroscience

1

1

10

4

Pharmacology

1

1

10

5

Neurophysiology

1

1

10

Yoko Amada

×

4

Publications

97

Citations

4

H-Index

YearCitations

Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4 H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats

Hiroshi Yamashita, K Ohno, Yoko Amada,

Journal of Pharmacology and Experimental Therapeutics

2004

32

Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy Japanese Male Subjects: Results from Single- and Multiple-Dose Studies

Hiromi Iitsuka, Tomoaki Tokuno, Yoko Amada,

Clinical Drug Investigation

2013

30

Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist

K Ohno, Rie Tsutsumi, Naoyuki Matsumoto,

Journal of Pharmacology and Experimental Therapeutics

2003

25

Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats

Hiroshi Yamashita, K Ohno, Yoko Amada,

Naunyn-Schmiedeberg s Archives of Pharmacology

2004

10

Page 1